152 related articles for article (PubMed ID: 24839329)
1. Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?
Lydon P; Gandhi G; Vandelaer J; Okwo-Bele JM
Bull World Health Organ; 2014 May; 92(5):382-4. PubMed ID: 24839329
[No Abstract] [Full Text] [Related]
2. GAVI funding meeting exceeds expectations.
Usher AD
Lancet; 2011 Jun; 377(9784):2165-6. PubMed ID: 21714163
[No Abstract] [Full Text] [Related]
3. [Insufficient vaccination is a threat against world health].
Gjersvik PJ
Tidsskr Nor Laegeforen; 2003 Mar; 123(6):831. PubMed ID: 12693127
[No Abstract] [Full Text] [Related]
4. Using private demand studies to calculate socially optimal vaccine subsidies in developing countries.
Cook J; Jeuland M; Maskery B; Lauria D; Sur D; Clemens J; Whittington D
J Policy Anal Manage; 2009; 28(1):6-28. PubMed ID: 19090047
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a comprehensive immunization program serving high-risk, uninsured adults.
Wilson KJ; Brown HS; Patel U; Tucker D; Becker K
Prev Med; 2020 Jan; 130():105860. PubMed ID: 31678176
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on the development and use of economic evidence for immunization decision-making in a developing country.
Molina-Aguilera IB
Vaccine; 2015 May; 33 Suppl 1():A6-7. PubMed ID: 25919176
[No Abstract] [Full Text] [Related]
7. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
8. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
[TBL] [Abstract][Full Text] [Related]
9. The future of routine immunization in the developing world: challenges and opportunities.
Shen AK; Fields R; McQuestion M
Glob Health Sci Pract; 2014 Dec; 2(4):381-94. PubMed ID: 25611473
[TBL] [Abstract][Full Text] [Related]
10. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
11. An analysis of government immunization program expenditures in lower and lower middle income countries 2006-12.
Nader AA; de Quadros C; Politi C; McQuestion M
Health Policy Plan; 2015 Apr; 30(3):281-8. PubMed ID: 24561878
[TBL] [Abstract][Full Text] [Related]
12. Immunizing the world.
Gates B; Gates M
Newsweek; 2000 Dec; 136(26A):72-3. PubMed ID: 11147309
[No Abstract] [Full Text] [Related]
13. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.
Jauregui B; Garcia AG; Bess Janusz C; Blau J; Munier A; Atherly D; Mvundura M; Hajjeh R; Lopman B; Clark AD; Baxter L; Hutubessy R; de Quadros C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1(0 1):A28-33. PubMed ID: 25919170
[TBL] [Abstract][Full Text] [Related]
14. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
[TBL] [Abstract][Full Text] [Related]
15. [Tropical vaccination, the paradox].
Buisson Y
Med Trop (Mars); 2007 Aug; 67(4):319. PubMed ID: 17926786
[No Abstract] [Full Text] [Related]
16. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel L
Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
[TBL] [Abstract][Full Text] [Related]
17. Integrated package approach in delivering interventions during immunisation campaigns in a complex environment in Papua New Guinea: a case study.
Vince JD; Datta SS; Toikilik S; Lagani W
Vaccine; 2014 Aug; 32(36):4614-9. PubMed ID: 24795224
[TBL] [Abstract][Full Text] [Related]
18. The cost structure of routine infant immunization services: a systematic analysis of six countries.
Geng F; Suharlim C; Brenzel L; Resch SC; Menzies NA
Health Policy Plan; 2017 Oct; 32(8):1174-1184. PubMed ID: 28575193
[TBL] [Abstract][Full Text] [Related]
19. Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011-20.
Ozawa S; Clark S; Portnoy A; Grewal S; Brenzel L; Walker DG
Health Aff (Millwood); 2016 Feb; 35(2):199-207. PubMed ID: 26858370
[TBL] [Abstract][Full Text] [Related]
20. Game dynamic model of optimal budget allocation under individual vaccination choice.
Deka A; Bhattacharyya S
J Theor Biol; 2019 Jun; 470():108-118. PubMed ID: 30904449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
